• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 3. Alt-proteins: A promising future
• 4. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

Introduction to 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid (CAS No. 40197-20-4)

5-bromo-1H-1,3-benzodiazole-2-carboxylic acid (CAS No. 40197-20-4) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique chemical structure and properties, has garnered considerable attention due to its potential in the development of novel therapeutic agents.

The chemical structure of 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid consists of a benzodiazole ring with a bromine substituent at the 5-position and a carboxylic acid group at the 2-position. This arrangement imparts specific reactivity and biological activity, making it an attractive candidate for various medicinal applications.

Recent studies have highlighted the potential of 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid in the treatment of neurological disorders. For instance, research published in the Journal of Medicinal Chemistry has shown that derivatives of this compound exhibit potent neuroprotective effects. These derivatives are being investigated for their ability to modulate neurotransmitter systems and protect neurons from oxidative stress and inflammation.

In addition to its neuroprotective properties, 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid has also shown promise in cancer research. Studies have demonstrated that certain analogs of this compound can inhibit the growth of cancer cells by interfering with key signaling pathways. For example, a study published in the Cancer Research journal reported that a derivative of 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid effectively suppressed the proliferation of breast cancer cells by targeting the PI3K/AKT signaling pathway.

The synthetic accessibility of 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid is another factor contributing to its widespread use in research. Various synthetic routes have been developed to produce this compound efficiently and cost-effectively. One such method involves the reaction of 5-bromobenzeneboronic acid with 2-chloroacetyl chloride followed by cyclization to form the benzodiazole ring. This synthetic approach allows for the easy modification of the molecule, facilitating the exploration of structure-activity relationships (SAR) and the development of optimized derivatives.

The physicochemical properties of 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid, including its solubility and stability, are crucial for its application in drug development. The compound is generally stable under standard laboratory conditions but may require specific storage conditions to maintain its integrity over extended periods. Its solubility in various solvents can be adjusted through functional group modifications, enhancing its utility in different experimental setups.

In terms of safety and handling, while 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid is not classified as a hazardous material, it is important to follow standard laboratory safety protocols when working with this compound. Proper personal protective equipment (PPE) should be worn, and appropriate ventilation should be ensured to minimize exposure risks.

The potential applications of 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid extend beyond medicinal chemistry. In materials science, this compound has been explored for its use in the development of functional materials with unique electronic and optical properties. For instance, researchers have synthesized polymers incorporating this benzodiazole derivative to create materials with enhanced conductivity and photoluminescence.

In conclusion, 5-bromo-1H-1,3-benzodiazole-2-carboxylic acid (CAS No. 40197-20-4) is a multifaceted compound with significant potential in various scientific fields. Its unique chemical structure and properties make it an invaluable tool for researchers working on drug discovery, materials science, and other advanced applications. As ongoing research continues to uncover new insights into its behavior and utility, this compound is likely to play an increasingly important role in future scientific advancements.

• 2849-93-6(1H-1,3-benzodiazole-2-carboxylic acid)
• 144167-50-0(Ethyl 5-bromo-1H-benzo[d]imidazole-2-carboxylate)
• 1221790-39-1(1H-benzimidazole-2-carboxylic acid dihydrate)
• 1159827-21-0(6-Bromo-imidazo1,5-apyridine-3-carboxylic Acid)
• 885280-26-2(5-bromo-1H-1,3-benzodiazole-2-carbaldehyde)
• 540516-28-7((5-bromo-1H-1,3-benzodiazol-2-yl)methanol)
• 885280-00-2(methyl 6-bromo-1H-benzimidazole-2-carboxylate)
• 849776-47-2(1H-Benzimidazole-2-carboxylic acid monohydrate)
• 1263060-63-4(7-Bromo-1H-benzimidazole-2-carboxylic acid)
• 1159831-00-1(7-Bromoimidazo1,5-apyridine-3-carboxylic Acid)